COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

NCT04832932 ·Status: ACTIVE_NOT_RECRUITING

An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants

NCT03563950 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab

NCT05002517 ·Status: UNKNOWN ·Phase: PHASE3

Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.

NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3

Risks of Bacterial and Fungal Superinfection in Patients With COVID-19

NCT05256316 ·Status: COMPLETED

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

NCT07110636 ·Status: RECRUITING ·Phase: NA

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects

NCT01769417 ·Status: COMPLETED ·Phase: PHASE1

Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia

NCT04636554 ·Status: NO_LONGER_AVAILABLE

Evaluation of Antibody Tests for COVID-19

NCT04360954 ·Status: COMPLETED

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

NCT04332094 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants

NCT04301310 ·Status: WITHDRAWN ·Phase: PHASE1

COVID-19 Vaccination AZV 2021-2023

NCT05589233 ·Status: COMPLETED

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442 ·Status: COMPLETED

Topical Antibacterial Agents for Prevention of COVID-19

NCT05449392 ·Status: COMPLETED ·Phase: PHASE1

TOcilizumab and Covid-19 : Risk of Severe INfection

NCT05017441 ·Status: UNKNOWN

Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.

NCT04934215 ·Status: COMPLETED

Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19

NCT04353518 ·Status: UNKNOWN ·Phase: PHASE3

Dysbiosis & Long COVID

NCT06825819 ·Status: RECRUITING

Tocilizumab in Coronavirus-19 Positive Patients

NCT04423042 ·Status: UNKNOWN ·Phase: PHASE3

Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers

NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

NCT06805994 ·Status: RECRUITING ·Phase: PHASE1

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant

NCT05695196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

NCT00406549 ·Status: COMPLETED

Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)

NCT05085522 ·Status: UNKNOWN

Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients

NCT06681025 ·Status: COMPLETED